The 130th Annual Meeting of APHA |
Christopher H. Bates, BS and DaDera L. Moore, MSW, MPH. Office of Public Health Sciences/Office of HIV/AIDS Policy, U.S Department of Health and Human Services, 200 Independence Ave, SW, Room 736E, Washington, DC 20201, 202-690-5560, CBates@osophs.dhhs.gov
RARE, as requested by the U.S. Congress in its Minority AIDS Initiative, was developed to work in partnership with local community officials, public health personnel and community leaders, to provide multi-disciplinary technical assistance to help fight HIV/AIDS within highly impacted ethnic/racial minority communities. By using the RARE methodology, participants in the project are able to: conduct rapid assessments that monitor the dynamics of local HIV/AIDS epidemics and their impact on vulnerable populations; identify rapid responses that are tailored to maximize HIV prevention and increase access to care; and build rapid evaluation to monitor the impact of intervention efforts on targeted communities. In Phase I, eligibility criteria targeted areas with the greatest need: metropolitan statistical areas with populations of 500,000 or greater; at least 50% of living AIDS cases within the MSA are among African Americans and Hispanics, combined; and 1,500 or more living AIDS cases among African Americans and Hispanics combined. Phase I was conducted in eleven U.S. cities and the U.S. Virgin Islands. Currently, Phase II eligibility criteria target communities that are: Eligible Metropolitan Areas or Emerging Communities as defined by the Ryan White C.A.R.E. Act; jurisdictions with at least 1,500 AIDS cases, 51% among African Americans and Hispanics; or represented by a member of a minority congressional caucus. RARE highlights the importance of identifying the dynamic social mixing patterns of populations in high-risk areas. Understanding the behaviors, attitudes, and values of these populations will illuminate how to best position HIV/AIDS and substance abuse prevention, care, and treatment interventions.
Learning Objectives:
Keywords: Federal Initiatives, HIV/AIDS
Presenting author's disclosure statement:
Organization/institution whose products or services will be discussed: U.S. Department of Health and Human Services
I have a significant financial interest/arrangement or affiliation with any organization/institution whose products or services are being discussed in this session.
Relationship: employment